trial

Symptom Based Treatment Affects Brain Plasticity - the Role of Verbal Auditory Hallucinations

NCTId NCT02722915
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 81 (actual)
Sponsored by RWTH Aachen University
Primary completion 2019-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
81 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2016-07
Primary completion
2019-12
Eligibility
ALL · 18 Years · 75 Years

Interventions & indications

Drugs
fMRINeurofeedbackPANASAVHRSSF36

Sponsors

RWTH Aachen UniversityLead Sponsor

Investigators

1
Klaus Mathiak, Prof MD PhDPrincipal Investigator

Sites

1 total
Aachen, Germany

Facts & assertions

4 sourced
Enrollment
81
Phase
NA
Primary Completion Date
2019-12
Status
COMPLETED
relationships
The graph out of here
drug
fMRI
drug
Neurofeedback
drug
PANAS
drug
AVHRS
drug
SF36
drug
lead_sponsor
RWTH Aachen University
company
indication
Hallucinations, Verbal Auditory
indication
Hallucinations
indication
Schizophrenia
indication
investigator
Klaus Mathiak, Prof MD PhD
person